维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Loughlin AM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The management of malignant ureteral obstruction treated with ureteral stents显示文摘	Ganatra AM Loughlin KR	2005	J Urol2005，174，6：	1
2	Genome-wide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis显示文摘	Valdes AM Loughlin J Timms KM		0，，06：	1
3	Sex and ethnic differences in the association of ASPN,CALM1 ,COL2A1 ,COMP and FRZB with genetic susceptibility to osteoarthritis of knee 显示文摘	Valdes AM Loughlin J Oene MV	2007	Arthritis Rheum2007，1，：	1
4	Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) 显示文摘	Loughlin AM Marchant CD Adams W Barnett E Baxter R Black S	2012	Vac- cine2012，30，50：	1
5	The management of malignant ureteral obstruction treated with ureteral stents 显示文摘	Ganatra AM Loughlin KR	2005	Urology2005，174，6：	1
6	Pevalence and correlates of HCV infections among methadone treatment attendees:implications for HCV treatment显示文摘	Loughlin AM Schwartz R Strathdee SA	2004	Int J Drug Policy2004，15，：	1
7	The management of malignant ureteral obstruction treated with ureteral stents显示文摘	Ganatra AM Loughlin KR	2005	J Urul2005，174，6：	1
8	Prevalence and correlares of HCV infection among methadone maintenance attend- ees:implications for HCV treatment 显示文摘	Loughlin AM Schwartz R Strathdee SA	2004	International Journal of DrugPolicy2004，15，2：	1
9	pevalence and correlates of HCV infections among methadone treatment at tendees: implications for HCV treatment 显示文摘	Loughlin AM Schwartz R St rathdee SA	2004	Int J Drug Policy2004，15，：	1
10	The management of malignant ureteral obstruction treated with ureteral stents 显示文摘	Ganatra AM Loughlin KR	2005	J Urol2005，174，：	1
11	Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the knee 显示文摘	Valdes AM Loughlin J Oene MV	2007	Arthritis Rheum2007，56，1：	1
12	Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAEES)显示文摘	Loughlin AM Marchant CD Adams W	2012	Vaccine2012，30，50：	1
13	The management of malignant ureteralobstruction treated with ureteral stents 显示文摘	Ganatra AM Loughlin KR	2005	J Urol2005，174，：	1
14	Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) 显示文摘	Loughlin AM Marchant CD Adams W Barnett E Baxter R Black S	2012	Vac- cine2012，30，50：	1
15	The management of malignant ureteral obstruction treated with ureteral stents显示文摘	Ganatra AM Loughlin KR		0，，06：	1
16	The management of malignant ureteral obstruction treated with ureteral stents显示文摘	Ganatra AM Loughlin KR	2005	J Urol2005，174，6：	1
17	The management of malignant ureteral ob- struction treated with ureteral stents显示文摘	Ganatra AM Loughlin KR	2005	J Urol2005，174，6：	1
18	The changing epidemiology of invasive bacterial infections in Massachusetts children,1984 through 1991显示文摘	Loughlin AM Marchant CD Lell SM	1995	Am J Public Health1995，85，3：	1
19	Genomewide association scan identifies a prostaglandin-endoperoxide synthase 2 variant involved in risk of knee osteoarthritis显示文摘	VALDES AM LOUGHLIN J TIMMS KM	2008	Am J Hum Genet2008，82，6：	1
20	The management of malignantureteral obstruction treated with ureteral stents显示文摘	Ganatra AM Loughlin KR	2005	J Urol2005，174，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示